Sustained Release
Showing 1 - 25 of 7,883
Generalized Anxiety Disorder Trial in Beijing (Toludesvenlafaxine Hydrochloride Sustained-release Tablet 80mg,
Not yet recruiting
- Generalized Anxiety Disorder
- Toludesvenlafaxine Hydrochloride Sustained-release Tablet 80mg
- +2 more
-
Beijing, ChinaPeking University Sixth Hospital
Aug 1, 2023
Crohn's Disease, Oral Ulcer Trial in Xi'an (Mesalazine Sustained-Release Tablets, Riboflavin Sodium Phosphate Injection)
Withdrawn
- Crohn's Disease
- Oral Ulcer
- Mesalazine Sustained-Release Tablets
- Riboflavin Sodium Phosphate Injection
-
Xi'an, Shaanxi, ChinaXijing Hospital
Jan 30, 2023
Partial Seizure Trial in Tianjin (Brivaracetam tablets (50mg/ tablet, BRIVIACT®, UCB), Brivaracetam sustained-release tablets
Active, not recruiting
- Partial Seizure
- Brivaracetam tablets (50mg/ tablet, BRIVIACT®, UCB)
- +2 more
-
Tianjin, Tianjin, ChinaTianjin Municipal People's Hospital
Jan 31, 2023
Hypertension Trial in Dongguan (Felodipine sustained release tablets (trade name: plendil®), Felodipine Controlled Release
Active, not recruiting
- Hypertension
- Felodipine sustained release tablets (trade name: plendil®)
- Felodipine Controlled Release Tablets
-
Dongguan, Guangdong, ChinaClinical Trial Centre of Dongguan Kanghua Hospital
Jan 31, 2023
Oxycodone Sustained-release Tablets for Moderate to Severe
Recruiting
- Cancer Pain
- +2 more
-
Zhengzhou, Henan, ChinaHenan Cancer Hospital
Jul 24, 2023
Pain Trial (JAN101 SR, Placebo)
Not yet recruiting
- Pain
- JAN101 SR
- Placebo
- (no location specified)
May 30, 2023
Liver Transplantation Trial (Tacrolimus Sustained-release Capsules)
Not yet recruiting
- Liver Transplantation
- Tacrolimus Sustained-release Capsules
- (no location specified)
Nov 25, 2023
Sarpogrelate, Blood Viscosity, Peripheral Arterial Disease Trial in Uijeongbu (Sarpogrelate Sustained Release/Aspirin, Aspirin)
Recruiting
- Sarpogrelate
- +3 more
- Sarpogrelate Sustained Release/Aspirin
- Aspirin
-
Uijeongbu, Gyeonggi-do, Korea, Republic ofThe Catholic University of Korea Uijeongbu St. Mary's Hospital
Feb 6, 2023
Cerebral Small Vessel Diseases Trial in Beijing (Pentoxifylline sustained-release tablets, Pentoxifylline sustained-release
Not yet recruiting
- Cerebral Small Vessel Diseases
- Pentoxifylline sustained-release tablets
- Pentoxifylline sustained-release tablets placebo
-
Beijing, ChinaBeijing Tiantan Hospital
Oct 13, 2022
Somatic Symptom Trial in Shanghai (toludesvenlafaxine HCl sustained-release tablets)
Not yet recruiting
- Somatic Symptom
- toludesvenlafaxine hydrochloride sustained-release tablets
-
Shanghai, Shanghai, ChinaShanghai Mental Health Center
May 6, 2023
Neuropathic Pain, Diabetes, Type 2 Trial in Korea, Republic of (pregabalin sustained release tablet, pregabalin immediate
Active, not recruiting
- Neuropathic Pain
- Diabetes Mellitus, Type 2
- pregabalin sustained release tablet
- pregabalin immediate release capsule
-
Cheongju, Chungcheongbuk-do, Korea, Republic of
- +7 more
Nov 14, 2022
Idiopathic Parkinson Disease Trial in Minneapolis (levodopa/carbidopa oral formulation A, levodopa/carbidopa oral formulation B,
Not yet recruiting
- Idiopathic Parkinson Disease
- levodopa/carbidopa oral formulation A
- +2 more
-
Minneapolis, MinnesotaUniversity of Minnesota
Jul 20, 2022
Pain, Acute, Opioid Use Trial in Edmonton (Hydromorphone)
Recruiting
- Pain, Acute
- Opioid Use
-
Edmonton, Alberta, CanadaUniversity of Alberta Hospital
May 12, 2022
Renal Transplant Recipients Trial in China (Tacrolimus sustained-release capsule)
Completed
- Renal Transplant Recipients
- Tacrolimus sustained-release capsule
-
Beijing, China
- +8 more
Jul 26, 2022
Prostate Cancer Trial in Guangzhou (Goserelin Acetate Sustained-Release Microspheres for Injection, Zoladex 10.8 MG Drug
Not yet recruiting
- Prostate Cancer
- Goserelin Acetate Sustained-Release Microspheres for Injection
- Zoladex 10.8 MG Drug Implant
-
Guangzhou, ChinaSun Yat-sen Memorial Hospital of Sun Yat-sen University
May 3, 2023
Idiopathic Pulmonary Fibrosis Trial in Cincinnati (Esbriet 267 MG Oral Capsule, EXCL-100, 600 MG Oral Tablet)
Not yet recruiting
- Idiopathic Pulmonary Fibrosis
- Esbriet 267 MG Oral Capsule
- EXCL-100, 600 MG Oral Tablet
- (no location specified)
Jun 24, 2022
Huntington Disease, Tardive Dyskinesia Trial in Shanghai (LPM3770164 sustained release tablet, LPM3770164 sustained release
Not yet recruiting
- Huntington Disease
- Tardive Dyskinesia
- LPM3770164 sustained release tablet
- LPM3770164 sustained release tablet simulant
-
Shanghai, Shanghai, ChinaShanghai Mental Health Center
Feb 3, 2022
MDD Trial in Shanghai (Toludesvenlafaxine HCl sustained-release tablets)
Not yet recruiting
- Major Depressive Disorder
- Toludesvenlafaxine hydrochloride sustained-release tablets
-
Shanghai, Shanghai, ChinaShanghai Mental Health Center
Sep 7, 2023
MDD Trial in Shanghai (Toludivenlafaxine HCl sustained-release tablets)
Recruiting
- Major Depressive Disorder
- Toludivenlafaxine hydrochloride sustained-release tablets
-
Shanghai, Shanghai, ChinaShanghai Mental Health Center
Jun 14, 2023
Preterm Birth Trial (Progesterone Sustained-release vaginal gel)
Not yet recruiting
- Preterm Birth
- Progesterone Sustained-release vaginal gel
- (no location specified)
Mar 15, 2023
Attention Deficit Disorder, ADHD Trial in Culver City (Centanafadine SR)
Completed
- Attention Deficit Disorder
- Attention Deficit Hyperactivity Disorder
- Centanafadine SR
-
Culver City, CaliforniaFor additional information regarding sites, contact 844-687-8522
Apr 1, 2022
Cocaine Use Disorder Trial in Lexington (Sustained Release d-amphetamine, Money)
Recruiting
- Cocaine Use Disorder
- Sustained Release d-amphetamine
- Money
-
Lexington, KentuckyLaboratory of Human Behavioral Pharmacology
Jan 25, 2023
Tension-Type Headache Trial in Rawalpindi (sustained natural apophyseal glides (SNAGS), suboccipital muscle release,
Active, not recruiting
- Tension-Type Headache
- sustained natural apophyseal glides (SNAGS)
- +2 more
-
Rawalpindi, Punjab, PakistanFauji Foundation Hospital
May 22, 2023